Sebetralstat, KalVista Pharmaceuticals‘ investigational on-demand treatment for swelling attacks in people with hereditary angioedema (HAE), led to a…
Articles by Patricia Inácio, PhD
The first case of a patient developing angioedema accompanied by hives after treatment with solifenacin, a medication commonly used…
Lack of awareness about rare diseases, such as hereditary angioedema (HAE), contributes to their often long and delayed diagnosis,…
Intellia Therapeutics has completed dosing the first group of patients enrolled in a Phase 1/2 clinical trial testing its…
In rare cases, stroke-like symptoms, such as tingling in the face and the left arm, can occur during an acute…
Newbury Pharmaceuticals is launching its injectable therapy of icatibant, the active agent of Firazyr, in Sweden and Norway…
Orladeyo (berotralstat), an approved therapy for preventing swelling attacks in hereditary angiodema (HAE), was effective at controlling attacks…
Short-term treatment with Berinert, a plasma-derived form of the C1 inhibitor protein, successfully prevented acute swelling attacks in a…
Spanish patients with hereditary angioedema reported fewer severe attacks and longer delays for treatment with Firazyr (icatibant injection)…
Favipiravir, an antiviral medication used to treat influenza and, more recently, COVID-19, may trigger angioedema in some individuals, a…